SEARCH

SEARCH BY CITATION

References

  • Bacigalupo, A., Brand, R., Oneto, R., Bruno, B., Socie, G., Passweg, J., Locasciulli, A., Van Lint, M.T., Tichelli, A., McCann, S., Marsh, J., Ljungman, P., Hows, J., Marin, P. & Schrezenmeier, H. (2000a) Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy – The European Group for Blood and Marrow Transplantation experience. Seminars in Hematology, 37, 6980.
  • Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Carotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A. (2000b) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood, 95, 19311934.
  • Boswell, A., Evans, L., Rigg, K. & Shehata, M. (2005) The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months’ posttransplant. Transplantation Proceedings, 37, 884885.
  • Camitta, B.M., Thomas, E.D., Nathan, D.G., Santos, G., Gordon-Smith, E.C., Gale, R.P., Rappeport, J.M. & Storb, R. (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood, 48, 6370.
  • Eisen, H.J., Kobashigawa, J., Keogh, A., Bourge, R., Renlund, D., Mentzer, R., Alderman, E., Valantine, H., Dureau, G., Mancini, D., Mamelok, R., Gordon, R., Wang, W., Mehra, M., Constanzo, M.R., Hummel, M. & Johnson, J. (2005) Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. Journal of Heart and Lung Transplantation, 24, 517525.
  • Frickhofen, N. & Rosenfeld, S.J. (2000) Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Seminars in Hematology, 37, 5668.
  • Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, F., Freund, M., Meusers, P., Salama, A. & Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New England Journal of Medicine, 324, 12971304.
  • Gaur, L.K., Nitta, Y., Kennedy, E., Lernmark, A., Nelson, K.A., Allen, M. & Nepom, G.T. (2002) Induction of islet allotolerance in nonhuman primates. Annals of the New York Academy of Sciences, 958, 199203.
  • Genestier, L., Fournel, S., Flacher, M., Assossou, O., Revillard, J.P. & Bonnefoy-Berard, N. (1998) Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood, 91, 23602368.
  • Ginzler, E.M., Dooley, M.A., Aranow, C., Kim, M.Y., Buyon, J., Merrill, J.T., Petri, M., Gilkeson, G.S., Wallace, D.J., Weisman, M.H. & Appel, G.B. (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. New England Journal of Medicine, 353, 22192228.
  • Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A.M. & Adorini, L. (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. Journal of Immunology, 167, 19451953.
  • Majithia, V. & Harisdangkul, V. (2005) Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology (Oxford), 44, 386389.
  • Mathew, T.H. (1998) A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation, 65, 14501454.
  • Meriggioli, M.N., Ciafaloni, E., Al-Hayk, K.A., Rowin, J., Tucker-Lipscomb, B., Massey, J.M. & Sanders, D.B. (2003) Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability. Neurology, 61, 14381440.
  • Merion, R.M., Howell, T. & Bromberg, J.S. (1998) Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation, 65, 14811489.
  • Mohty, M., De Lavallade, H., Faucher, C., Bilger, K., Vey, N., Stoppa, A.M., Gravis, G., Coso, D., Viens, P., Gastaut, J.A. & Blaise, D. (2004) Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation, 34, 527530.
  • Mok, C.C. & Lai, K.N. (2002) Mycophenolate mofetil in lupus glomerulonephritis. American Journal of Kidney Diseases, 40, 447457.
  • Neumann, F., Graef, T., Tapprich, C., Vaupel, M., Steidl, U., Germing, U., Fenk, R., Hinke, A., Haas, R. & Kobbe, G. (2005) Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings. Bone Marrow Transplantation, 35, 10891093.
  • Rosenfeld, S.J., Kimball, J., Vining, D. & Young, N.S. (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood, 85, 30583065.
  • Rosenfeld, S., Follmann, D., Nunez, O. & Young, N.S. (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA, 289, 11301135.
  • Smith, A.G., O'Reilly, R.J., Hansen, J.A. & Martin, P.J. (1985) Specific antibody-blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment of aplastic anemia. Blood, 66, 721723.
  • Young, N.S. (2002) Acquired aplastic anemia. Annals of Internal Medicine, 136, 534546.
  • Zuckermann, A., Reichenspurner, H., Birsan, T., Treede, H., Deviatko, E., Reichart, B. & Klepetko, W. (2003) Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. Journal of Thoracic and Cardiovascular Surgery, 125, 891900.